Abstract
Necrosis is considered to be an unregulated and chaotic cell death. However, recent advances in cell death strategies support necroptosis as a form of regulated programmed necrotic cell death. In response to TNF-α or Fas ligands, necroptosis can be induced by cell death receptors in multiple cell lines in the presence of a caspase inhibitor z-VAD; necroptotic cell death has been found to play an important role in normal development, immunity, inflammation, cancer, and human diseases. In this chapter, the molecular mechanisms governing necroptosis, recent findings about the upstream and downstream schema of necroptosis, and potential therapeutic targets in neurological disorders are discussed. After being activated by TNF-α (or Fas ligands) and death receptors, receptor-interacting proteins 1 and 3 (RIP1 and RIP3) form a complex, which play a central role in the induction of necroptosis. RIP3 phosphorylates and activates mitochondrial proteins mixed lineage kinase domain-like protein (MLKL) and PGAM5, resulting in the execution of necroptosis by dynamin-related protein 1, the GTPase that controls mitochondrial fission. Some small molecules such as necrostain-1 and necrosulfonamide target different steps of necroptosis and impede the progress of necroptosis. FADD, caspase-8, CLIP, and CYLD positively or negatively regulate RIP1-/RIP3-dependent necroptosis by different mechanisms. Recent studies demonstrate the involvement of necroptosis in many neurological disorders including stroke, trauma, neonatal hypoxic–ischemic encephalopathy, and Huntington’s disease. As a potential therapeutic target, the understanding of necroptotic mechanisms will provide new insights to develop more potent neuroprotectants and specific therapeutic strategies for clinical treatments of neurological disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIF:
-
Apoptosis-inducing factor
- ANT:
-
Adenine nucleotide translocase
- Aur-A:
-
Aurora-A kinase
- BHA:
-
Butylated hydroxyanisole
- CCI:
-
Controlled cortical impact
- cIAP1/2:
-
Apoptosis protein 1/2
- CypA:
-
Cyclophilin A
- CypD:
-
Cyclophilin D
- DRP1:
-
Dynamin-related protein 1
- FADD:
-
Fas-associated protein with death domain
- FLIPL:
-
FLICE-like inhibitory protein long
- GLUD1:
-
Glutamate dehydrogenase 1
- GLUL:
-
Glutamate–ammonia ligase
- HI:
-
Hypoxia–ischemia
- HIE:
-
Hypoxic–ischemic encephalopathy
- HMGB1:
-
High-mobility group box 1 protein
- HSP90:
-
Heat shock protein
- IAPs:
-
Inhibitors of apoptosis
- MEFs:
-
Mouse embryonic fibroblasts
- MKRN1:
-
Makorin Ring Finger Protein 1
- MLKL:
-
Mixed lineage kinase domain-like protein
- OGD:
-
Oxygen–glucose deprivation
- Plk1:
-
Polo-like kinase 1
- RHIM:
-
RIP homotypic interaction motif
- RIP:
-
Receptor-interacting protein
- ROS:
-
Reactive oxygen species
- TNFR1:
-
TNF receptor 1
- TNF-α:
-
Tumor necrosis factor-α
- z-VAD:
-
z-VAD-fmk
References
Andrabi, S. A., Dawson, T. M., & Dawson, V. L. (2008). Mitochondrial and nuclear cross talk in cell death: Parthanatos. Annals of the New York Academy of Sciences, 1147, 233–241.
Ashwal, S., & Pearce, W. J. (2001). Animal models of neonatal stroke. Current Opinion in Pediatrics, 13, 506–516.
Beal, M. F. (1992). Role of excitotoxicity in human neurological disease. Current Opinion in Neurobiology, 2, 657–662.
Bell, B. D., Leverrier, S., Weist, B. M., Newton, R. H., Arechiga, A. F., Luhrs, K. A., Morrissette, N. S., & Walsh, C. M. (2008). FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proceedings of the National Academy of Sciences of the United States of America, 105, 16677–16682.
Bertrand, M. J., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008). cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Molecular Cell, 30, 689–700.
Biton, S., & Ashkenazi, A. (2011). NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling. Cell, 145, 92–103.
Bodmer, J. L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., & Tschopp, J. (2000). TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biology, 2, 241–243.
Cabon, L., Galan-Malo, P., Bouharrour, A., Delavallee, L., Brunelle-Navas, M. N., Lorenzo, H. K., Gross, A., & Susin, S. A. (2012). BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation. Cell Death and Differentiation, 19, 245–256.
Ch’en, I. L., Beisner, D. R., Degterev, A., Lynch, C., Yuan, J., Hoffmann, A., & Hedrick, S. M. (2008). Antigen-mediated T cell expansion regulated by parallel pathways of death. Proceedings of the National Academy of Sciences of the United States of America, 105, 17463–17468.
Challa, S., & Chan, F. K. (2010). Going up in flames: Necrotic cell injury and inflammatory diseases. Cellular and Molecular Life Sciences, 67, 3241–3253.
Chavez-Valdez, R., Martin, L. J., Flock, D. L., & Northington, F. J. (2012). Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience, 219, 192–203.
Chen, T., Fei, F., Jiang, X. F., Zhang, L., Qu, Y., Huo, K., & Fei, Z. (2012a). Down-regulation of Homer1b/c attenuates glutamate-mediated excitotoxicity through endoplasmic reticulum and mitochondria pathways in rat cortical neurons. Free Radical Biology & Medicine, 52, 208–217.
Chen, W. W., Yu, H., Fan, H. B., Zhang, C. C., Zhang, M., Zhang, C., Cheng, Y., Kong, J., Liu, C. F., Geng, D., & Xu, X. (2012b). RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons. Journal of Neurochemistry, 120, 70–77.
Cho, Y. S., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K. (2009). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell, 137, 1112–1123.
Christofferson, D. E., & Yuan, J. (2010). Cyclophilin A release as a biomarker of necrotic cell death. Cell Death and Differentiation, 17, 1942–1943.
Chuang, J. Y., Wang, Y. T., Yeh, S. H., Liu, Y. W., Chang, W. C., & Hung, J. J. (2008). Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Molecular Biology of the Cell, 19, 1139–1151.
Coffey, E. T., Smiciene, G., Hongisto, V., Cao, J., Brecht, S., Herdegen, T., & Courtney, M. J. (2002). c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. The Journal of Neuroscience, 22, 4335–4345.
Declercq, W., Vanden Berghe, T., & Vandenabeele, P. (2009). RIP kinases at the crossroads of cell death and survival. Cell, 138, 229–232.
Deeraksa, A., Pan, J., Sha, Y., Liu, X. D., Eissa, N. T., Lin, S. H., & Yu-Lee, L. Y. (2013). Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene. 32(24), 2973–2983. doi: 10.1038/onc.2012.309. [Epub ahead of print].
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005). Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nature Chemical Biology, 1, 112–119.
Delavallee, L., Cabon, L., Galan-Malo, P., Lorenzo, H. K., & Susin, S. A. (2011). AIF-mediated caspase-independent necroptosis: A new chance for targeted therapeutics. IUBMB Life, 63, 221–232.
Dillon, C. P., Oberst, A., Weinlich, R., Janke, L. J., Kang, T. B., Ben-Moshe, T., Mak, T. W., Wallach, D., & Green, D. R. (2012). Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Reports, 1, 401–407.
Dunai, Z. A., Imre, G., Barna, G., Korcsmaros, T., Petak, I., Bauer, P. I., & Mihalik, R. (2012). Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS One, 7, e41945. doi:10.1371/journal.pune.0041945. Epub 2012 Jul 31.
Duprez, L., Bertrand, M. J., Vanden Berghe, T., Dondelinger, Y., Festjens, N., & Vandenabeele, P. (2012). Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. Journal of Biological Chemistry, 287, 14863–14872.
Edinger, A. L., & Thompson, C. B. (2004). Death by design: Apoptosis, necrosis and autophagy. Current Opinion in Cell Biology, 16, 663–669.
Ekshyyan, O., & Aw, T. Y. (2004). Apoptosis: A key in neurodegenerative disorders. Current Neurovascular Research, 1, 355–371.
Enesa, K., Zakkar, M., Chaudhury, H., le Luong, A., Rawlinson, L., Mason, J. C., Haskard, D. O., Dean, J. L., & Evans, P. C. (2008). NF-kappaB suppression by the deubiquitinating enzyme Cezanne: A novel negative feedback loop in pro-inflammatory signaling. Journal of Biological Chemistry, 283, 7036–7045.
Feoktistova, M., Geserick, P., Kellert, B., Dimitrova, D. P., Langlais, C., Hupe, M., Cain, K., MacFarlane, M., Hacker, G., & Leverkus, M. (2011). cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Molecular Cell, 43, 449–463.
Festjens, N., Kalai, M., Smet, J., Meeus, A., Van Coster, R., Saelens, X., & Vandenabeele, P. (2006a). Butylated hydroxyanisole is more than a reactive oxygen species scavenger. Cell Death and Differentiation, 13, 166–169.
Festjens, N., Vanden Berghe, T., & Vandenabeele, P. (2006b). Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response. Biochimica et Biophysica Acta, 1757, 1371–1387.
Festjens, N., Vanden Berghe, T., Cornelis, S., & Vandenabeele, P. (2007). RIP1, a kinase on the crossroads of a cell’s decision to live or die. Cell Death and Differentiation, 14, 400–410.
Gallo, K. A., & Johnson, G. L. (2002). Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nature Reviews Molecular Cell Biology, 3, 663–672.
Gu, X. H., Xu, R., Yuan, G. L., Lu, H., Gu, B. R., & Xie, H. P. (2010). Preparation of chlorogenic acid surface-imprinted magnetic nanoparticles and their usage in separation of traditional Chinese medicine. Analytica Chimica Acta, 675, 64–70.
Gunther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H., Waldner, M. J., Hedrick, S. M., Tenzer, S., Neurath, M. F., & Becker, C. (2011). Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature, 477, 335–339.
Gunther, C., Neumann, H., Neurath, M. F., & Becker, C. (2013). Apoptosis, necrosis and necroptosis: Cell death regulation in the intestinal epithelium. Gut, 62(7), 1062–1071. Epub 2012 Jun 11. Review.
Halestrap, A. P., & Brenner, C. (2003). The adenine nucleotide translocase: A central component of the mitochondrial permeability transition pore and key player in cell death. Current Medicinal Chemistry, 10, 1507–1525.
Han, J., Zhong, C. Q., & Zhang, D. W. (2011). Programmed necrosis: Backup to and competitor with apoptosis in the immune system. Nature Immunology, 12, 1143–1149.
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009). Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell, 137, 1100–1111.
Hitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008). Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell, 135, 1311–1323.
Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J. L., Schneider, P., Seed, B., & Tschopp, J. (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunology, 1, 489–495.
Hong, S. J., Dawson, T. M., & Dawson, V. L. (2004). Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends in Pharmacological Sciences, 25, 259–264.
Jang, M. S., Lee, S. J., Kang, N. S., & Kim, E. (2011). Cooperative phosphorylation of FADD by Aur-A and Plk1 in response to taxol triggers both apoptotic and necrotic cell death. Cancer Research, 71, 7207–7215.
Jouan-Lanhouet, S., Arshad, M. I., Piquet-Pellorce, C., Martin-Chouly, C., Le Moigne-Muller, G., Van Herreweghe, F., Takahashi, N., Sergent, O., Lagadic-Gossmann, D., Vandenabeele, P., Samson, M., & Dimanche-Boitrel, M. T. (2012). TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death and Differentiation, 19, 2003–2014.
Kaiser, W. J., Upton, J. W., Long, A. B., Livingston-Rosanoff, D., Daley-Bauer, L. P., Hakem, R., Caspary, T., & Mocarski, E. S. (2011). RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature, 471, 368–372.
Kazama, H., Ricci, J. E., Herndon, J. M., Hoppe, G., Green, D. R., & Ferguson, T. A. (2008). Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity, 29, 21–32.
Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., & Leder, P. (1998). The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity, 8, 297–303.
Kerr, J. F., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer, 26, 239–257.
Kitanaka, C., & Kuchino, Y. (1999). Caspase-independent programmed cell death with necrotic morphology. Cell Death and Differentiation, 6, 508–515.
Klionsky, D. J., Cuervo, A. M., & Seglen, P. O. (2007). Methods for monitoring autophagy from yeast to human. Autophagy, 3, 181–206.
Kramer, G., Erdal, H., Mertens, H. J., Nap, M., Mauermann, J., Steiner, G., Marberger, M., Biven, K., Shoshan, M. C., & Linder, S. (2004). Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Research, 64, 1751–1756.
Kreuz, S., Siegmund, D., Rumpf, J. J., Samel, D., Leverkus, M., Janssen, O., Hacker, G., Dittrich-Breiholz, O., Kracht, M., Scheurich, P., & Wajant, H. (2004). NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. The Journal of Cell Biology, 166, 369–380.
Krishnakumar, R., & Kraus, W. L. (2010). The PARP side of the nucleus: Molecular actions, physiological outcomes, and clinical targets. Molecular Cell, 39, 8–24.
Lau, A., & Tymianski, M. (2010). Glutamate receptors, neurotoxicity and neurodegeneration. Pflügers Archiv, 460, 525–542.
Lee, E. W., Kim, J. H., Ahn, Y. H., Seo, J., Ko, A., Jeong, M., Kim, S. J., Ro, J. Y., Park, K. M., Lee, H. W., Park, E. J., Chun, K. H., & Song, J. (2012). Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nature Communications, 3, 978.
Lewis, J., Devin, A., Miller, A., Lin, Y., Rodriguez, Y., Neckers, L., & Liu, Z. G. (2000). Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. Journal of Biological Chemistry, 275, 10519–10526.
Li, Y., Yang, X., Ma, C., Qiao, J., & Zhang, C. (2008). Necroptosis contributes to the NMDA-induced excitotoxicity in rat’s cultured cortical neurons. Neuroscience Letters, 447, 120–123.
Lin, Y., Choksi, S., Shen, H. M., Yang, Q. F., Hur, G. M., Kim, Y. S., Tran, J. H., Nedospasov, S. A., & Liu, Z. G. (2004). Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. Journal of Biological Chemistry, 279, 10822–10828.
Linder, S., Olofsson, M. H., Herrmann, R., & Ulukaya, E. (2010). Utilization of cytokeratin-based biomarkers for pharmacodynamic studies. Expert Review of Molecular Diagnostics, 10, 353–359.
Long, J. S., & Ryan, K. M. (2012). New frontiers in promoting tumour cell death: Targeting apoptosis, necroptosis and autophagy. Oncogene, 31, 5045–5060.
Lu, J. V., & Walsh, C. M. (2012). Programmed necrosis and autophagy in immune function. Immunological Reviews, 249, 205–217.
Lu, J. V., Weist, B. M., van Raam, B. J., Marro, B. S., Nguyen, L. V., Srinivas, P., Bell, B. D., Luhrs, K. A., Lane, T. E., Salvesen, G. S., & Walsh, C. M. (2011). Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proceedings of the National Academy of Sciences of the United States of America, 108, 15312–15317.
Macurek, L., Lindqvist, A., & Medema, R. H. (2009). Aurora-A and hBora join the game of Polo. Cancer Research, 69, 4555–4558.
McComb, S., Cheung, H. H., Korneluk, R. G., Wang, S., Krishnan, L., & Sad, S. (2012). cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death and Differentiation, 19, 1791–1801.
Meloni, B. P., Meade, A. J., Kitikomolsuk, D., & Knuckey, N. W. (2011). Characterisation of neuronal cell death in acute and delayed in vitro ischemia (oxygen-glucose deprivation) models. Journal of Neuroscience Methods, 195, 67–74.
Meylan, E., & Tschopp, J. (2005). The RIP kinases: Crucial integrators of cellular stress. Trends in Biochemical Sciences, 30, 151–159.
Moquin, D., & Chan, F. K. (2010). The molecular regulation of programmed necrotic cell injury. Trends in Biochemical Sciences, 35, 434–441.
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005). Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature, 434, 652–658.
Northington, F. J., Chavez-Valdez, R., Graham, E. M., Razdan, S., Gauda, E. B., & Martin, L. J. (2011). Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. Journal of Cerebral Blood Flow and Metabolism, 31, 178–189.
O’Donnell, M. A., Perez-Jimenez, E., Oberst, A., Ng, A., Massoumi, R., Xavier, R., Green, D. R., & Ting, A. T. (2011). Caspase 8 inhibits programmed necrosis by processing CYLD. Nature Cell Biology, 13, 1437–1442.
Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G. S., & Green, D. R. (2011). Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature, 471, 363–367.
Perez-Pinzon, M. A., Stetler, R. A., & Fiskum, G. (2012). Novel mitochondrial targets for neuroprotection. Journal of Cerebral Blood Flow and Metabolism, 32, 1362–1376.
Pop, C., Oberst, A., Drag, M., Van Raam, B. J., Riedl, S. J., Green, D. R., & Salvesen, G. S. (2011). FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochemical Journal, 433, 447–457.
Rebe, C., Cathelin, S., Launay, S., Filomenko, R., Prevotat, L., L’Ollivier, C., Gyan, E., Micheau, O., Grant, S., Dubart-Kupperschmitt, A., Fontenay, M., & Solary, E. (2007). Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood, 109, 1442–1450.
Rosenbaum, D. M., Degterev, A., David, J., Rosenbaum, P. S., Roth, S., Grotta, J. C., Cuny, G. D., Yuan, J., & Savitz, S. I. (2010). Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. Journal of Neuroscience Research, 88, 1569–1576.
Sarkar, F. H., & Li, Y. (2006). Markers of apoptosis. Methods in Molecular Medicine, 120, 147–160.
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418, 191–195.
Schon, E. A., & Przedborski, S. (2011). Mitochondria: The next (neurode)generation. Neuron, 70, 1033–1053.
Schweichel, J. U., & Merker, H. J. (1973). The morphology of various types of cell death in prenatal tissues. Teratology, 7, 253–266.
Shembade, N., Ma, A., & Harhaj, E. W. (2010). Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science, 327, 1135–1139.
Simenc, J., & Lipnik-Stangelj, M. (2012). Staurosporine induces apoptosis and necroptosis in cultured rat astrocytes. Drug and Chemical Toxicology, 35, 399–405
Stanger, B. Z., Leder, P., Lee, T. H., Kim, E., & Seed, B. (1995). RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81, 513–523.
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., & Wang, X. (2012). Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell, 148, 213–227.
Temkin, V., Huang, Q., Liu, H., Osada, H., & Pope, R. M. (2006). Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Molecular and Cellular Biology, 26, 2215–2225.
Tenev, T., Bianchi, K., Darding, M., Broemer, M., Langlais, C., Wallberg, F., Zachariou, A., Lopez, J., MacFarlane, M., Cain, K., & Meier, P. (2011). The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Molecular Cell, 43, 432–448.
Teng, X., Degterev, A., Jagtap, P., Xing, X., Choi, S., Denu, R., Yuan, J., & Cuny, G. D. (2005). Structure-activity relationship study of novel necroptosis inhibitors. Bioorganic & Medicinal Chemistry Letters, 15, 5039–5044.
Teng, X., Keys, H., Jeevanandam, A., Porco, J. A., Jr., Degterev, A., Yuan, J., & Cuny, G. D. (2007). Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors. Bioorganic & Medicinal Chemistry Letters, 17, 6836–6840.
Teng, X., Keys, H., Yuan, J., Degterev, A., & Cuny, G. D. (2008). Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors. Bioorganic & Medicinal Chemistry Letters, 18, 3219–3223.
Tourneur, L., & Chiocchia, G. (2010). FADD: A regulator of life and death. Trends in Immunology, 31, 260–269.
van Wijk, S. J., & Hageman, G. J. (2005). Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion. Free Radical Biology & Medicine, 39, 81–90.
Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., & Kroemer, G. (2010). Molecular mechanisms of necroptosis: An ordered cellular explosion. Nature Reviews Molecular Cell Biology, 11, 700–714.
Vanlangenakker, N., Vanden Berghe, T., Bogaert, P., Laukens, B., Zobel, K., Deshayes, K., Vucic, D., Fulda, S., Vandenabeele, P., & Bertrand, M. J. (2011). cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death and Differentiation, 18, 656–665.
Vanlangenakker, N., Vanden Berghe, T., & Vandenabeele, P. (2012). Many stimuli pull the necrotic trigger, an overview. Cell Death and Differentiation, 19, 75–86.
Vosler, P. S., Graham, S. H., Wechsler, L. R., & Chen, J. (2009). Mitochondrial targets for stroke: Focusing basic science research toward development of clinically translatable therapeutics. Stroke, 40, 3149–3155.
Wang, K., Li, J., Degterev, A., Hsu, E., Yuan, J., & Yuan, C. (2007). Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5. Bioorganic & Medicinal Chemistry Letters, 17, 1455–1465.
Wang, L., Du, F., & Wang, X. (2008). TNF-alpha induces two distinct caspase-8 activation pathways. Cell, 133, 693–703.
Wang, Z., Jiang, H., Chen, S., Du, F., & Wang, X. (2012). The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell, 148, 228–243.
Welz, P. S., Wullaert, A., Vlantis, K., Kondylis, V., Fernandez-Majada, V., Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., & Pasparakis, M. (2011). FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature, 477, 330–334.
West, T., Atzeva, M., & Holtzman, D. M. (2006). Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathways. Neurobiology of Disease, 22, 523–537.
Wright, A., Reiley, W. W., Chang, M., Jin, W., Lee, A. J., Zhang, M., & Sun, S. C. (2007). Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD. Developmental Cell, 13, 705–716.
Xu, X., Chua, C. C., Gao, J., Hamdy, R. C., & Chua, B. H. (2006). Humanin is a novel neuroprotective agent against stroke. Stroke, 37, 2613–2619.
Xu, X., Chua, C. C., Kong, J., Kostrzewa, R. M., Kumaraguru, U., Hamdy, R. C., & Chua, B. H. (2007). Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. Journal of Neurochemistry, 103, 2004–2014.
Xu, X., Chua, C. C., Zhang, M., Geng, D., Liu, C. F., Hamdy, R. C., & Chua, B. H. (2010a). The role of PARP activation in glutamate-induced necroptosis in HT-22 cells. Brain Research, 1343, 206–212.
Xu, X., Chua, K. W., Chua, C. C., Liu, C. F., Hamdy, R. C., & Chua, B. H. (2010b). Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Research, 1355, 189–194.
Yahiro, K., Satoh, M., Nakano, M., Hisatsune, J., Isomoto, H., Sap, J., Suzuki, H., Nomura, F., Noda, M., Moss, J., & Hirayama, T. (2012). Low-density Lipoprotein Receptor-related Protein-1 (LRP1) mediates autophagy and apoptosis caused by Helicobacter pylori VacA. Journal of Biological Chemistry, 287, 31104–31115.
Yeh, W. C., Itie, A., Elia, A. J., Ng, M., Shu, H. B., Wakeham, A., Mirtsos, C., Suzuki, N., Bonnard, M., Goeddel, D. V., & Mak, T. W. (2000). Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity, 12, 633–642.
You, Z., Savitz, S. I., Yang, J., Degterev, A., Yuan, J., Cuny, G. D., Moskowitz, M. A., & Whalen, M. J. (2008). Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. Journal of Cerebral Blood Flow and Metabolism, 28, 1564–1573.
Yuan, J., & Kroemer, G. (2010). Alternative cell death mechanisms in development and beyond. Genes & Development, 24, 2592–2602.
Zhang, D. W., Shao, J., Lin, J., Zhang, N., Lu, B. J., Lin, S. C., Dong, M. Q., & Han, J. (2009). RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science, 325, 332–336.
Zhang, D., Lin, J., & Han, J. (2010). Receptor-interacting protein (RIP) kinase family. Cellular & Molecular Immunology, 7, 243–249.
Zhang, H., Zhou, X., McQuade, T., Li, J., Chan, F. K., & Zhang, J. (2011a). Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature, 471, 373–376.
Zhang, Z., Shi, R., Weng, J., Xu, X., Li, X. M., Gao, T. M., & Kong, J. (2011b). The proapoptotic member of the Bcl-2 family Bcl-2/E1B-19 K-interacting protein 3 is a mediator of caspase-independent neuronal death in excitotoxicity. FEBS Journal, 278, 134–142.
Zhao, J., Jitkaew, S., Cai, Z., Choksi, S., Li, Q., Luo, J., & Liu, Z. G. (2012). Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proceedings of the National Academy of Sciences of the United States of America, 109, 5322–5327.
Zheng, W., Degterev, A., Hsu, E., Yuan, J., & Yuan, C. (2008). Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7. Bioorganic & Medicinal Chemistry Letters, 18, 4932–4935.
Zhu, S., Zhang, Y., Bai, G., & Li, H. (2011). Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington’s disease. Cell Death and Disease, 2, e115.
Acknowledgments
This chapter and related studies were supported by grants 30700245, 81071095, and 81120108011 from the National Natural Science Foundation of China (to XX) and the Priority Academic Program Development of Jiangsu Higher Education Institutions of China.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Chen, J., Kostrzewa, R.M., Xu, X. (2014). Necroptosis, a Potential Therapeutic Target for Neurological Disorders. In: Kostrzewa, R. (eds) Handbook of Neurotoxicity. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5836-4_166
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5836-4_166
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5835-7
Online ISBN: 978-1-4614-5836-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences